TY  -  
T1  - Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria 
SN  -  /  
UR  - http://hdl.handle.net/10138/353308 
T3  -  
A1  - The FinnDiane Study Group; Jansson Sigfrids, Fanny; Stechemesser, Lars; Dahlström, Emma H.; Forsblom, Carol M.; Harjutsalo, Valma; Weitgasser, Raimund; Taskinen, Marja Riitta; Groop, Per Henrik 
A2  -  
PB  -  
Y1  - 2022 
LA  - eng 
AB  - Objectives: We studied apolipoprotein C-III (apoC-III) in relation to diabetic kidney disease (DKD), cardiovascular outcomes, and mortality in type 1 diabetes. Methods: The cohort comprised 3966 participants from the prospective observational Finnish Diabetic Nephropathy Study. Progression of DKD was determined from medical records. A major adverse cardiac event (MACE) was defined as acute myocardial infarction, coronary revascularization, stroke, or cardiovascular mortality through 2017. Cardio... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - apolipoprotein C-III; cardiovascular disease; diabetes mellitus; diabetic nephropathy; dyslipidemia; mortality; type 1; ENDOTHELIAL DYSFUNCTION; CHOLESTEROL; RISK; NEPHROPATHY; INSULIN; INFLAMMATION; CIII; DYSLIPIDEMIA; ASSOCIATION; CORONARY-ARTERY-DISEASE; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -